November 17th, 2026FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System LymphomaThe FDA removed the PCNSL limitation of use from the liso-cel label in LBCL, making it the second CAR T-cell therapy with this update.Read more
November 13th, 2026OncLive Weekly News Quiz (11/13/2026): Did You Miss Crucial TGCT, Breast Cancer, Bladder Cancer, and Lymphoma Updates?Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.Read more
November 10th, 2026Prizlon-Cel Nets FDA RMAT and Fast Track Designations in R/R LBCLThe anti-CD19/CD20 CAR T-cell therapy will be studied in the phase 2 ABZT-121 trial after progression on commercial CAR T-cell therapy.Read more
November 9th, 2026FDA Flashback: Hematologic Cancer Decisions and News From October 2026Read a refresh of hematologic cancer FDA news from October 2026, including the approval of a noncovalent BTK inhibitor in untreated CLL/SLL.Read more
November 6th, 2026OncLive Weekly News Quiz (11/6/2026): Did You Miss Crucial Hematologic, Lung, and Desmoid Tumor Updates?Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.Read more